Development of a HIV-1 vaccine using an orally-administered, replication-competent adenovirus serotype 4 vector expressing Env clade C glycoprotein

por Alexander, J, Gurwith, M, Mendy, J, Vang, L, Manayani, D, Avanzini, J, Guenther, B, Farness, P, Haynes, BF, Liao, H, Montefiori, DC, LaBranche, CC, Mayall, T
Publicado 2012